Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Abtl0812
2. Abtl-0812
3. Alpha-hydroxylinoleic Acid
4. 2-hydroxy-9z,12z-octadecadienoic Acid
1. Abtl-0812
2. Alpha-hydroxylinoleic Acid
3. Abtl0812
4. 2-hydroxylinoleic Acid
5. 0de74tj7ez
6. 9,12-octadecadienoic Acid, 2-hydroxy-, (9z,12z)-
7. Scln0812
8. Scln-0812
9. Chebi:136927
10. Lp10218
11. Lp-10218
12. 57818-44-7
13. (9z,12z)-2-hydroxyoctadeca-9,12-dienoic Acid
14. (alpha)-hydroxylinoleic Acid
15. 2-hydroxy-9z,12z-octadecadienoic Acid
16. (9z,12z)-2-hydroxy-9,12-octadecadienoic Acid
17. 9,12-octadecadienoic Acid, 2-hydroxy-, (z,z)-
18. Hydroxylinoleic Acid
19. Ibrilatazar [inn]
20. Unii-0de74tj7ez
21. Schembl320069
22. Orb1708145
23. Dtxsid301258077
24. .alpha.-hydroxylinoleic Acid
25. Hy-u00141
26. Lmfa02000290
27. S9611
28. Akos040740632
29. Cs-7178
30. (9z,12z)-2-hydroxyoctadecadienoic Acid
31. Da-79166
32. Ms-24253
33. G16137
34. Rac-(2r)-(9z,12z)-2-hydroxyoctadeca-9,12-dienoic Acid
| Molecular Weight | 296.4 g/mol |
|---|---|
| Molecular Formula | C18H32O3 |
| XLogP3 | 5.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 14 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 57.5 |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 295 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
76
PharmaCompass offers a list of Ibrilatazar API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ibrilatazar manufacturer or Ibrilatazar supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibrilatazar manufacturer or Ibrilatazar supplier.
A Ibrilatazar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ibrilatazar, including repackagers and relabelers. The FDA regulates Ibrilatazar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ibrilatazar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ibrilatazar supplier is an individual or a company that provides Ibrilatazar active pharmaceutical ingredient (API) or Ibrilatazar finished formulations upon request. The Ibrilatazar suppliers may include Ibrilatazar API manufacturers, exporters, distributors and traders.
Ibrilatazar Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ibrilatazar GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ibrilatazar GMP manufacturer or Ibrilatazar GMP API supplier for your needs.
A Ibrilatazar CoA (Certificate of Analysis) is a formal document that attests to Ibrilatazar's compliance with Ibrilatazar specifications and serves as a tool for batch-level quality control.
Ibrilatazar CoA mostly includes findings from lab analyses of a specific batch. For each Ibrilatazar CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ibrilatazar may be tested according to a variety of international standards, such as European Pharmacopoeia (Ibrilatazar EP), Ibrilatazar JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ibrilatazar USP).
